Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Current Deferred Revenue (2021 - 2025)

Historic Current Deferred Revenue for Biote (BTMD) over the last 5 years, with Q3 2025 value amounting to $3.2 million.

  • Biote's Current Deferred Revenue rose 813.12% to $3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 million, marking a year-over-year increase of 813.12%. This contributed to the annual value of $3.0 million for FY2024, which is 136.58% down from last year.
  • Latest data reveals that Biote reported Current Deferred Revenue of $3.2 million as of Q3 2025, which was up 813.12% from $3.1 million recorded in Q2 2025.
  • Biote's Current Deferred Revenue's 5-year high stood at $3.2 million during Q3 2025, with a 5-year trough of $1.7 million in Q4 2021.
  • Its 5-year average for Current Deferred Revenue is $2.6 million, with a median of $2.9 million in 2024.
  • Per our database at Business Quant, Biote's Current Deferred Revenue skyrocketed by 5277.35% in 2023 and then tumbled by 338.71% in 2025.
  • Biote's Current Deferred Revenue (Quarter) stood at $1.7 million in 2021, then rose by 15.25% to $2.0 million in 2022, then skyrocketed by 52.77% to $3.0 million in 2023, then dropped by 1.37% to $3.0 million in 2024, then increased by 6.89% to $3.2 million in 2025.
  • Its Current Deferred Revenue was $3.2 million in Q3 2025, compared to $3.1 million in Q2 2025 and $3.0 million in Q1 2025.